EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Screening of Covalent Kinase Inhibitors Yields Hits for Cysteine Protease USP7 / HAUSP

Larissa N Ernst iD, Simon J Jaag iD, Valentin R Wydra iD, Benedikt Masberg iD, Cornelius Knappe iD, Stefan Gerstenecker iD, Ricardo A M Serafim iD, Xiaojun Julia Liang, Nico J Seidler iD, Michael Lämmerhofer iD, Matthias Gehringer iD, Frank M Boeckler iD

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s513591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Larissa N Ernst und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Biochemistry, Eberhard Karls Universität Tübingen, Laboratory for Molecular Design and Pharmaceutical Biophysics, Institut…. Hauptthemen laut MEDLINE: Ubiquitin-Specific Peptidase 7, Protein Kinase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Specific Peptidase 7Protein Kinase InhibitorsHumansStructure-Activity RelationshipMolecular StructureSmall Molecule LibrariesDose-Response Relationship, Drug

Stichwörter der Autor:innen

covalent cysteine modificationdifferential scanning fluorimetry (DSF)intact protein mass spectrometrynucleophilic aromatic substitution (SNAr)repurposing of kinase inhibitors

Substanzen

Ubiquitin-Specific Peptidase 7Protein Kinase InhibitorsUSP7 protein, humanSmall Molecule Libraries

Autor:innen und Institutionen

  • Department of Pharmacy and Biochemistry, Eberhard Karls Universität Tübingen, Laboratory for Molecular Design and Pharmaceutical Biophysics, Institute of Pharmaceutical Sciences, Tübingen, 72076, Germany.
  • Department of Pharmacy and Biochemistry, Eberhard Karls Universität, Pharmaceutical (Bio-)Analysis, Institute of Pharmaceutical Sciences, Tübingen, 72076, Germany.
  • Department of Pharmacy and Biochemistry, Eberhard Karls Universität, Pharmaceutical Chemistry, Institute of Pharmaceutical Sciences, Tübingen, 72076, Germany.
  • Department of Medicinal Chemistry, Eberhard Karls Universität Tübingen, Faculty of Medicine, Institute for Biomedical Engineering, Tübingen, 72076, Germany.
  • Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls Universität Tübingen, Tübingen, 72076, Germany.
  • Interfaculty Institute for Biomedical Informatics (IBMI), Eberhard Karls Universität Tübingen, Tübingen, 72076, Germany.

ORCID-Profile: Larissa N Ernst, Simon J Jaag, Valentin R Wydra, Benedikt Masberg, Cornelius Knappe, Stefan Gerstenecker, Ricardo A M Serafim, Nico J Seidler, Michael Lämmerhofer, Matthias Gehringer, Frank M Boeckler

Zitieren

APA

Ernst, L. N., Jaag, S. J., Wydra, V. R., Masberg, B., Knappe, C., Gerstenecker, S., Serafim, R. A. M., Liang, X. J., Seidler, N. J., Lämmerhofer, M., Gehringer, M., & Boeckler, F. M. (2025). Screening of Covalent Kinase Inhibitors Yields Hits for Cysteine Protease USP7 / HAUSP. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s513591

Vancouver

Ernst LN, Jaag SJ, Wydra VR, Masberg B, Knappe C, Gerstenecker S, et al. Screening of Covalent Kinase Inhibitors Yields Hits for Cysteine Protease USP7 / HAUSP. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s513591

BibTeX
@article{Ernst2025,
  author = {Ernst, Larissa N and Jaag, Simon J and Wydra, Valentin R and Masberg, Benedikt and Knappe, Cornelius and Gerstenecker, Stefan and Serafim, Ricardo A M and Liang, Xiaojun Julia and Seidler, Nico J and Lämmerhofer, Michael and Gehringer, Matthias and Boeckler, Frank M},
  title = {Screening of Covalent Kinase Inhibitors Yields Hits for Cysteine Protease USP7 / HAUSP},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s513591}
}
Kostenlos starten →